(CSE: AIAI | OTCQB: AINMF | FRA: PF0) Clinical trials are one of the most expensive, complex, and failure-prone parts…...

Global markets are once again being reminded of the growing cost of geopolitical and trade tensions. Fresh data showing Japan’s…...

China is accelerating its push into green hydrogen at a pace that is capturing global investor attention, with more than…...

Generative AI continues to move from experimental pilots to full-scale deployment, and nowhere is the momentum more visible than in…...

For more than two years, one defining feature of the U.S. equity landscape has been the unwavering resilience of retail…...

In a year defined by rapid advances in artificial intelligence and a race toward measurable ROI, enterprise spending on AI-driven…...

The accelerating convergence of traditional finance and digital assets is taking another decisive step forward. At a time when institutional…...

The race to secure America’s next-generation AI infrastructure is intensifying—and capital is flooding in at unprecedented levels. Investors have been…...